Board of Concord Drugs approves change in directorate

At meeting held on 01 June 2022
The Board of Concord Drugs at its meeting held on 01 June 2022 has approved appointment of K Sumeela as an Additional Director of the company with effect from 01 June 2022. The Board also approved the resignation of P Chandrakala as Independent Director of the company with effect from 01 June 2022.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Buzzing :
Greece in crisisTravel & Budget & EuropeSaaS $ Email MarketingHarnautBlacklisting Policy 2Question Paper Leak 2A big moment for small armsAI in Financial Markets: How Technology is Changing Investing'India's size and diversity make it a powerful innovation engine'Datanomics: Housing, gold loans drive household debt to a decade highSamrat ChoudharyEl Nino
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jun 02 2022 | 9:56 AM IST

